Vertex Pharmaceuticals is strutting toward its Q1 earnings report with a 22.3% stock surge this year, brushing up against its 52-week high. While analysts expect a dip in earnings per share, revenue ...

Complete BiomX Inc. stock information by Barron's. View real-time PHGE stock price and news, along with industry-best analysis.